Our weekly list of news, reports, and information about home health and hospice care. Learn about new studies, trends, CMS regulations and more.
Advisory Research Inc. bought a new stake in LHC Group, Inc. (NASDAQ:LHCG) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,941 shares of the health services provider’s stock, valued at approximately $2,157,000. Advisory Research Inc. owned about 0.07% of LHC Group at the end of the most recent reporting period.
Northern Trust Corp lifted its stake in Kindred Healthcare, Inc. (NYSE:KND) by 3.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,072,867 shares of the health services provider’s stock after purchasing an additional 33,893 shares during the quarter. Northern Trust Corp owned about 1.18% of Kindred Healthcare worth $9,655,000 as of its most recent filing with the Securities & Exchange Commission.
AMEDISYS posted another strong quarter, continuing a strong trend that began a few years ago after the hiring if CEO Paul Kusserow. Stock up almost 700% last five years. The company's two largest business units, Home Health and Hospice, continue to perform well. The company's Home Health segment is a leader among large peers in clinical care quality, as measured by the federal government. New federal policies on Medicare reimbursement may challenge Home Health companies like AMEDISYS, but the company is doing the right things to prepare for a value-based purchasing world. Federal policy will remain a risk.
Humana (NYSE: HUM) could be close to creating an “end-to-end health care experience for American seniors,” supported by its Kindred at Home ownership and a potential joint venture with Walgreens Boots Alliance (NYSE: WBA). That’s according to a Nov. 20 note from Leerink analysts; the note was issued after a Wall Street Journal report that Humana and Walgreens are in talks and could take equity stakes in each other. On Wednesday night, Walgreens Executive Vice Chairman and CEO Stefano Pessina said that the two companies are indeed in negotiations, Forbes reported.